Fig. 8From: Multilayer network analysis of the drugs development cycle in the global pharmaceutical industryThe number of bow tie components in the drug pipeline network by countries. We categorized each component using the types of business entities and only showed the top four countries located in the GWCC, namely, a US, b JPN, c GBR, and d CHNBack to article page